je.st

Home › ipr

Tag: ipr

IPR Quarterly, Second Quarter, 2015

2015-09-05 00:00:03| PortlandOnline

PDF Document, 93kbCategory: Quarterly Reports

Tags: quarter quarterly ipr quarter quarterly

IPR Quarterly, First Quarter, 2015

2015-09-04 23:59:38| PortlandOnline

PDF Document, 95kbCategory: Quarterly Reports

Tags: quarter quarterly ipr quarter quarterly

Kyle Bass Loses Round 1 of IPR Attack Against Pharma/Biotech Patents

2015-08-29 06:06:18| Biotech - Topix.net

On August 24, 2015, the Patent Trial and Appeal Board declined institution of two petitions filed by Coalition For Affordable Drugs for Inter Partes Reviews of Acorda's patents covering Ampyra, a billion-dollar drug for treating multiple sclerosis. The Petitioner, Coalition For Affordable Drugs, is a wholly owned subsidiary of a hedge fund managed by Kyle Bass, which appears to have little to do with the life science and drug industry other than filing IPR petitions against patents owned by pharmaceutical and biotechnology companies.

Tags: round attack bass patents